Hanbo Zhang, Nimira S Alimohamed, Naveen S Basappa, Tina Cheng, Michael Chu, Nanette Cox-Kennett, D Scott Ernst, Amelie Fontaine, Sunita Ghosh, Daniel Y C Heng, Richard Littleton, Scott North, Cindy Railton, Irwindeep Sandhu, Trevor H Stenson, Douglas A Stewart, Christopher P Venner, Peter M Venner, Michael P Kolinsky
INTRODUCTION: High-dose chemotherapy with autologous stem-cell transplantation (HDCASCT) is standard therapy for metastatic germ cell tumors (mGCTs) in patients whose disease progresses during or after conventional chemotherapy. We conducted a retrospective review of HDC-ASCT in relapsed mGCT patients in the province of Alberta, Canada over the past two decades. METHODS: Patients with mGCTs who received HDC-ASCT at two provincial cancer referral centers from 2000-2018 were identified from institutional databases...
November 20, 2023: Canadian Urological Association Journal